TickerFacts.

Viatris Inc (VTRS): Revenue

Annual figures by period end, from SEC filings.

$14.30B
Year ended 2025-12-31
$14.74B
Trailing 12 months to 2026-06-30
-4.2%
3-year compound annual growth
+3.7%
5-year compound annual growth
$17.89B2018-12-31: $11.43B2019-12-31: $11.50B2020-12-31: $11.95B2021-12-31: $17.89B2022-12-31: $16.26B2023-12-31: $15.43B2024-12-31: $14.74B2025-12-31: $14.30B$14.30B
2018-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$14.30B-3.0%2026-02-26, From 2025-01-01
2024-12-31$14.74B-4.5%2026-02-26, From 2024-01-01
2023-12-31$15.43B-5.1%2026-02-26, From 2023-01-01
2022-12-31$16.26B-9.1%2025-02-27, From 2022-01-01
2021-12-31$17.89B+49.7%2024-02-28, From 2021-01-01
2020-12-31$11.95B+3.9%2023-02-27, From 2020-01-01
2019-12-31$11.50B+0.6%2022-02-28, From 2019-01-01
2018-12-31$11.43Bn/a2021-03-01, From 2018-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Viatris Inc (VTRS)2025-12-31$14.30B-3.0%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$14.34B+1.0%
Vertex Pharmaceuticals Inc (VRTX)2025-12-31$12.00B+8.9%
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$17.26B+4.3%
Bausch Health Companies Inc. (BHC)2025-12-31$10.27B+6.7%
Zoetis Inc. (ZTS)2025-12-31$9.47B+2.3%
Organon & Co. (OGN)2025-12-31$6.22B-2.9%
BeOne Medicines Ltd. (ONC)2025-12-31$5.34B+40.2%
Elanco Animal Health Inc (ELAN)2025-12-31$4.71B+6.2%

Compare VTRS, REGN, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗